非甾体抗炎药用于全髋关节置换术后异位骨化预防:系统综述与荟萃分析
该系统综述与荟萃分析纳入29项研究,评估非选择性和选择性非甾体抗炎药(NSAIDs)预防全髋关节置换术(THA)后异位骨化(HO)的疗效。结果显示两类NSAIDs较安慰剂均显著降低HO形成风险,非选择性与选择性NSAIDs之间无显著差异。作者认为两者均可常规用于THA术后镇痛及预防HO。
核心结论
- 作者认为非选择性和选择性NSAIDs均是有效的HO预防措施,可在THA术后常规用于镇痛及预防HO。
- 吲哚美辛可作为非选择性NSAIDs中的基准药物,塞来昔布可作为选择性NSAIDs中的基准药物。
- 非选择性与选择性NSAIDs之间HO发生率无差异,医生可根据临床情况和患者个体因素选择其一。
研究设计与样本
- 系统综述与荟萃分析,共纳入29项符合纳入标准的研究。
- 进行系统文献检索,提取数据并生成森林图进行统计分析。
临床怎么用
- 作者认为非选择性和选择性NSAIDs均可常规用于THA术后镇痛及预防HO。
- 作者认为吲哚美辛可作为非选择性NSAIDs中的基准药物,塞来昔布可作为选择性NSAIDs中的基准药物。
- 作者认为非选择性与选择性NSAIDs之间HO发生率无差异,医生可根据临床情况和患者个体因素选择其一。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to assess the efficacy of non-selective and selective non-steroidal anti-inflammatory drugs (NSAIDs) in preventing heterotopic ossification (HO) after total hip arthroplasty (THA). METHODS: A thorough and systematic literature search was conducted and 29 studies were found that met inclusion criteria. Data were extracted and statistical analysis was carried out generating forest plots. RESULTS: Non-selective NSAIDs showed a significant decrease in the odds for forming HO after THA (odds ratio (OR) -1.35, confidence interval (CI) -1.83 to -0.86) when compared with placebo. Selective NSAIDs also showed a significant decrease in the odds for forming HO after THA when compared with placebo (OR -1.58, CI -2.41 to -0.75). When comparing non-selective NSAIDs with selective NSAIDs, there was no significant change in the odds for forming HO after THA (OR 0.22, CI -0.36 to 0.79). CONCLUSION: Our meta-analyses of all available data suggest that both non-selective and selective NSAIDs are effective HO prophylaxis and can be used routinely after THA for pain control as well as prevention of HO. Indomethacin may serve as the benchmark among non-selective NSAIDs and celecoxib among selective NSAIDs. There was no difference in the incidence of HO between non-selective and selective NSAIDs, allowing physicians to choose either based on the clinical scenario and patient-specific factors. Cite this article: Bone Joint J 2018;100-B:915-22.
引用
- Joice M, Vasileiadis GI, Amanatullah DF, et al. Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis. Bone Joint J. 2018. PMID: 29954195. doi:10.1302/0301-620X.100B7.BJJ-2017-1467.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。